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Conclusions
Data from this trial suggest that
diet complexity had a significant effect
on growth, but little to no effect on
intestine villus height. Supplemental
glutamine did not improve villus height
but did improve feed efficiency in the
third week of this 21-day growth study.
Additional research is needed to
examine the effects of glutamine on
intestine metabolism and function to
ascertain whether glutamine may be
beneficial in practical situations.
1Steven J. Kitt is a graduate student,
Phillip S. Miller is an associate professor,
Austin J. Lewis is a professor, and Robert L.
Fischer is a graduate student and research
technologist in the Department of Animal
Science.
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Figure 3. Feed efficiency of pigs fed diets differing in complexity and crystalline
glutamine concentration. Gln = glutamine.
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Summary and Implications
In two studies, mice were fed
diets containing either individual
conjugated linoleic acid (CLA) iso-
mers or a mixture of isomers in the
presence or absence of dietary essen-
tial fatty acids. Mice fed the C18:2
∆10,12 CLA isomer lost as much body
fat as mice fed a mixture of isomers.
This effect was not observed when the
mice were fed the C18:2 ∆9,11 isomer
or when feed intake was restricted. The
loss of body fat was much greater in
mice consuming an essential fatty acid
deficient diet versus a control diet.
This supports our hypothesis that for
CLA to deplete body fat, it must first be
metabolized in a manner similar to
linoleic acid. Furthermore, we sug-
gest that the loss of body fat may be
mediated by metabolism of CLA to an
isomer of arachidonic acid. Under-
standing the mechanism by which CLA
causes body fat loss, in pigs as well as
mice, will allow for greater regulation
of body fat content.
Introduction
Conjugated linoleic acid (CLA)
is a group of isomers of linoleic acid
(C18:2 ∆9,12), which, when consumed,
produce health benefits such as reduc-
ing the incidence of cancer and cardio-
vascular disease and reducing body
fat content. Furthermore, in swine,
dietary CLA has resulted in firmer
bellies, reduced backfat, and improved
feed efficiency. Our group previously
reported (Nebraska Swine Report 2001,
pg 27 – 28) that not only did dietary
CLA supplementation cause a loss of
body fat in mice, but that it also resulted
in programmed cell death, or apoptosis,
of fat cells. The basis for the following
two studies was to further determine
the mechanism by which CLA is caus-
ing both the body fat loss as well as the
apoptosis. The predominant naturally
occurring isomer is C18:2 ∆9,11 (CLA
9/11), whereas commercially synthe-
sized CLA products usually contain
approximately equal amounts of
C18:2 ∆10,12 (CLA 10/12) and CLA 9/11
as well as smaller quantities of other
isomers. The diverse benefits of CLA
may depend on different isomers. There-
fore our first objective was to determine
which isomer(s) are responsible for the
loss of body fat in mice.
Arachidonic acid (C20:4 ∆5,8,11,14)
is synthesized in animals from dietary
linoleic acid. Similarly, CLA 10/12 can
be metabolized to C20:4 ∆5,8,12,14. This
product of CLA metabolism could
antagonize the normal production of
prostaglandins from arachidonic acid.
Therefore, mice fed a diet deficient in
linoleic acid, and thus arachidonic acid,
may be especially sensitive to the anti-
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obesity effect of dietary CLA. Our sec-
ond objective was to compare the effect
of CLA in dietary essential fatty acid-
adequate and -deficient diets.
Procedures
Experiment 1
Seventy-two mixed sex mice were
allotted to one of five diets (each 7%
fat) and allowed to consume ad libitum,
except the Pair-Fed group, for 5 days:
Control purified diet with 7% soy
oil
Pair-Fed control diet at intake of CLA
Mix
CLA Mix 2% CLA mixture and 5%
soy oil
CLA 9/11 0.82% CLA 9/11 and 6.18%
soy oil
CLA 10/12 0.88% CLA 10/12 and 6.12%
soy oil
Individual isomers were included
the concentrations they were found at
in the CLA Mix diet. Feed intake and
body weight were measured daily.
After 5 days, the mice were killed and
retroperitoneal (RP) fat pads were
removed and weighed. Body fat was
determined on carcasses by ether
extraction.
Experiment 2
Eighty, newly weaned male mice
were fed either a control diet (7% soy
oil) or essential fatty acid deficient
(EFAD) diet (7% coconut oil) for 6
weeks. Next, half of the mice in each
group were supplemented with 0.5%
CLA mixture, replacing either soy or
coconut oil, for 2 weeks. Then the mice
were killed and RP fat pads, epididymal
(Epi) fat pads, and livers were removed
and weighed. Body fat was determined
by ether extraction.
Results
Experiment 1
Feed intake was reduced (P < 0.001)
in mice fed CLA Mix and CLA 10/12 as
Figure 1. Effect of CLA Mix or individual isomers on feed intake (Experiment 1). *CLA
10/12, CLA Mix, and Pair-Fed differ from Control (P < 0.001).
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Figure 2. Effect of CLA Mix or individual isomers on body weight (Experiment 1). No
effect of dietary treatment on body weight was detected.
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Table 1. Effect of dietary treatment on feed intake, body weight change, and fat pad
weights (Experiment 2).
Dietary Treatmentsd
Control CLA EFAD EFAD +CLA SEM
Feed intake, g/d
Before CLAe 3.79 3.79 3.82 3.82 0.12
After CLAe 4.45a 3.95 b 4.50a 3.85 b 0.08
Body wt. change, gf
Before CLAe 16.66 16.66 16.94 16.94 0.47
After CLAe 2.75a 1.55 b 2.55a -0.46c 0.30
RP wt., gg 0.37a 0.19 b 0.34a 0.09c 0.03
Epi wt., gh 0.61a 0.45 b 0.55a 0.21c 0.04
abcDifferent letters in a row indicate differences, P < 0.05.
dDietary treatments are as follows: Control – 7% soy oil diet for 8 weeks; CLA – 7% soy oil diet
for 6 weeks, 0.5% CLA mix + 6.5% soy oil diet for 2 weeks; EFAD – 7% coconut oil diet for 8 weeks;
and EFAD + CLA – 7% coconut oil diet for 6 weeks, 0.5% CLA + 6.5% coconut oil diet for 2 weeks.
eFeed intake and body weight change before CLA is the first six weeks of the study; after CLA is
the final 2 weeks of the study.
fBody weight change is calculated as the weight at the final week of the feeding period minus the
initial weight of that feeding period.
gRP = retroperitoneal fat pads.
hEpi = epididymal fat pads. (Continued on next page)
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on feed intake, body weight, or body
fat. However, when CLA was fed to
mice deficient in essential fatty acids its
effects were greatly amplified (P < 0.001);
a reduction of 73% in RP, 57% in Epi,
and 66% in total body fat (Figure 4).
Discussion
Our results indicate that CLA 10/12
is responsible for the loss of body fat
observed when mice are fed a mixture of
CLA isomers. This loss of body fat may
be mediated through metabolism of CLA
to an isomer of arachidonic acid. This
was the basis for the design of Study 2.
Arachidonic acid is a precursor to the
series 2 prostaglandins, some of which
appear to protect against cell death.
Therefore, CLA-mediated inhibition of
the conversion of arachidonic acid to
prostaglandin could explain the fat cell
death caused by feeding CLA. Essen-
tial fatty acids (linoleic and linolenic)
protect against the full effect of CLA,
which may indicate that CLA and these
fatty acids are metabolized via a com-
mon metabolic path.
The knowledge that CLA 10/12 is
responsible for the full fat-reducing-
effect of CLA will allow both research-
ers, as well as swine producers to more
accurately formulate diets on the active
CLA isomer (CLA 10/12), instead of on
the total CLA content. This becomes
especially important when different
sources of CLA are used as different
manufacturing procedures produce dif-
ferent ratios of isomers. In addition,
recognizing the metabolic pathway
through which CLA acts should facili-
tate development of better methods to
manipulate body fat in the future.
1Kim Hargrave is a graduate stu-
dent, Kristin Nollette is an under-
graduate student, Merlyn Nielsen is a
professor, and Jess Miner is an assis-
tant professor in the Department of
Animal Science.
Figure 3. Effect of CLA Mix or individual isomers on body fat (Experiment 1). abcBars with
different superscripts differ (P  < 0.10).
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Figure 4. Effect of essential fatty acid deficiency (EFAD) and CLA supplementation on
body fat (Experiment 2). abcBars with different superscripts differ (P < 0.001).
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well as the Pair-Fed mice, starting on
day 2 (Figure 1). However, there were
no significant differences in body weight
among dietary treatment groups in this
short time period (Figure 2). After 5
days of CLA supplementation, body
fat content of mice fed the CLA Mix and
the CLA 10/12 isomer was 20% less
(P < 0.10) than that of mice fed the
Control diet (Figure 3).
Experiment 2
Supplementation of CLA reduced
(P < 0.05) both feed intake and body
weight change in the final 2 weeks of
the study (Table 1). CLA reduced
(P < 0.001) RP (49%) and Epi (19%) fat
pad weights when added to the control
diet (Table 1). Furthermore, CLA
reduced total body fat by 27% (Figure
4). The EFAD diet alone had no effect
